Cargando…

Altered molecular specificity of surfactant phosphatidycholine synthesis in patients with acute respiratory distress syndrome

BACKGROUND: Acute respiratory distress syndrome (ARDS) is a life-threatening critical illness, characterised by qualitative and quantitative surfactant compositional changes associated with premature airway collapse, gas-exchange abnormalities and acute hypoxic respiratory failure. The underlying me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dushianthan, Ahilanandan, Goss, Victoria, Cusack, Rebecca, Grocott, Michael PW, Postle, Anthony D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226855/ https://www.ncbi.nlm.nih.gov/pubmed/25378080 http://dx.doi.org/10.1186/s12931-014-0128-8

Ejemplares similares

Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome - where do we go from here?
por: Dushianthan, Ahilanandan, et al.
Publicado: (2012)

Exogenous Surfactant Therapy in Acute Lung Injury/Acute Respiratory Distress Syndrome: The Need for a Revised Paradigm Approach
por: Dushianthan, Ahilanandan, et al.
Publicado: (2012)

Abnormal liver phosphatidylcholine synthesis revealed in patients with acute respiratory distress syndrome
por: Dushianthan, Ahilanandan, et al.
Publicado: (2018)

Phospholipid composition and kinetics in different endobronchial fractions from healthy volunteers
por: Dushianthan, Ahilanandan, et al.
Publicado: (2014)

Insight into erythrocyte phospholipid molecular flux in healthy humans and in patients with acute respiratory distress syndrome
por: Dushianthan, Ahilanandan, et al.
Publicado: (2019)

Perceptions of diagnosis and management of patients with acute respiratory distress syndrome: a survey of United Kingdom intensive care physicians
por: Dushianthan, Ahilanandan, et al.
Publicado: (2014)

Pulmonary Surfactant in Adult ARDS: Current Perspectives and Future Directions
por: Dushianthan, Ahilanandan, et al.
Publicado: (2023)

Alveolar Hyperoxia and Exacerbation of Lung Injury in Critically Ill SARS-CoV-2 Pneumonia
por: Dushianthan, Ahilanandan, et al.
Publicado: (2023)

Rapid Phospholipid Turnover after Surfactant Nebulization in Severe COVID-19 Infection: A Randomized Clinical Trial
por: Postle, Anthony D., et al.
Publicado: (2021)

Goal-directed haemodynamic therapy (GDHT) in surgical patients: systematic review and meta-analysis of the impact of GDHT on post-operative pulmonary complications
por: Dushianthan, Ahilanandan, et al.
Publicado: (2020)

A randomized controlled trial of nebulized surfactant for the treatment of severe COVID-19 in adults (COVSurf trial)
por: Dushianthan, Ahilanandan, et al.
Publicado: (2023)

Intensive care physicians’ perceptions of the diagnosis & management of patients with acute hypoxic respiratory failure associated with COVID-19: A UK based survey
por: Dushianthan, Ahilanandan, et al.
Publicado: (2021)

Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial
por: Dushianthan, Ahilanandan, et al.
Publicado: (2020)

Noninvasive ventilation for COVID-19-associated acute hypoxaemic respiratory failure: experience from a single centre
por: Sivaloganathan, Arjjana A., et al.
Publicado: (2020)

Surfactant alteration and replacement in acute respiratory distress syndrome
por: Günther, Andreas, et al.
Publicado: (2001)

Severe Parainfluenza Viral Infection—A Retrospective Study of Adult Intensive Care Patients
por: Watson, Adam, et al.
Publicado: (2023)

Improving physical function of patients following intensive care unit admission (EMPRESS): protocol of a randomised controlled feasibility trial
por: Cusack, Rebecca, et al.
Publicado: (2022)

Detailed Analysis of Primary Non-invasive Respiratory Support and Outcomes of Subjects With COVID-19 Acute Hypoxaemic Respiratory Failure
por: Booker, James, et al.
Publicado: (2022)

Prediction of mortality in critically-ill elderly trauma patients: a single centre retrospective observational study and comparison of the performance of trauma scores
por: Egglestone, Rebecca, et al.
Publicado: (2020)

The Role of Surfactant in Respiratory Distress Syndrome
por: Ma, Christopher Cheng-Hwa, et al.
Publicado: (2012)

Dynamic blood oxygen indices in mechanically ventilated COVID-19 patients with acute hypoxic respiratory failure: A cohort study
por: Bracegirdle, Luke, et al.
Publicado: (2022)

Effect of surfactant dose on outcomes in preterm infants with respiratory distress syndrome: the OPTI-SURF study protocol
por: Goss, Kevin Colin William, et al.
Publicado: (2020)

Surfactant replacement therapy for respiratory distress syndrome in preterm infants: United Kingdom national consensus
por: Banerjee, Sujoy, et al.
Publicado: (2019)

Prone Positioning in Mechanically Ventilated COVID-19 Patients: Timing of Initiation and Outcomes
por: Jackson, Alexander, et al.
Publicado: (2023)

Exogenous surfactant therapy for acute respiratory distress in infancy
por: Moreno, M., et al.
Publicado: (1996)

Aerosolized Surfactant for Preterm Infants with Respiratory Distress Syndrome
por: Brasher, Mandy, et al.
Publicado: (2021)

Prehospital administration of surfactant to a premature neonate in respiratory distress
por: Mize, Charles Haviland, et al.
Publicado: (2019)

Trial of aerosolised surfactant for preterm infants with respiratory distress syndrome
por: Jardine, Luke, et al.
Publicado: (2022)

Irrational prescription of surfactant replacement therapy in neonatal respiratory distress
por: Jahanmehr, Nader, et al.
Publicado: (2022)

Target product profile: aerosolized surfactant for neonatal respiratory distress
por: Rao, Suman, et al.
Publicado: (2023)

Provision of Microbiology, Infection Services and Antimicrobial Stewardship in Intensive Care: A Survey across the Critical Care Networks in England and Wales
por: Catton, Tim, et al.
Publicado: (2023)

FiO(2) Before Surfactant, but Not Time to Surfactant, Affects Outcomes in Infants With Respiratory Distress Syndrome
por: Kruczek, Piotr, et al.
Publicado: (2021)

Altered Lipid Composition of Surfactant and Lung Tissue in Murine Experimental Malaria-Associated Acute Respiratory Distress Syndrome
por: Scaccabarozzi, Diletta, et al.
Publicado: (2015)

Surfactant Protein D Is Altered in Experimental Malaria-Associated Acute Lung Injury/Acute Respiratory Distress Syndrome
por: Punsawad, Chuchard, et al.
Publicado: (2019)

Early Surfactant Therapy for Respiratory Distress Syndrome in Very Preterm Infants
por: Cucerea, Manuela, et al.
Publicado: (2023)

Pulmonary surfactant combined with budesonide in the treatment of neonatal respiratory distress syndrome
por: Guo, Hongxing, et al.
Publicado: (2023)

Conscious prone positioning during non-invasive ventilation in COVID-19 patients: experience from a single centre
por: Burton-Papp, Helmi C., et al.
Publicado: (2020)

Recurrent Pneumothorax in a Critically Ill Ventilated COVID-19 Patient
por: Rehnberg, Lucas, et al.
Publicado: (2020)

Lung Mechanics in COVID-19 Resemble Respiratory Distress Syndrome, Not Acute Respiratory Distress Syndrome: Could Surfactant Be a Treatment?
por: Koumbourlis, Anastassios C., et al.
Publicado: (2020)

Dry powder nebulization of a recombinant surfactant protein C-based surfactant for treatment of acute respiratory distress syndrome
por: Ruppert, C, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_pb2np0a1dmt237m1ai9jna9vft